Olaparib usage and dosage

Olaparib is a drug used for the maintenance treatment of adults with BRCA mutated advanced ovarian cancer, with the trade name Lynparza. It is a PARP inhibitor that inhibits polyADPribose polymerase (PARP), an enzyme involved in DNA repair. It fights cancers in people with hereditary BRCA1 or BRCA2 mutations, including some ovarian, breast and prostate cancers. In December 2014, Lynparza was approved by the European Medicines Agency (EMA) and the Food and Drug Administration (FDA) in the United States for use as a single drug.

Olaparib(Olaparib)The recommended dosage in the instructions is twice a day, 300mg each time. Continue treatment until disease progression or unacceptable toxicity. Follow all directions on your prescription label, and read any medication guides or inserts. Your doctor may occasionally change the dose, just follow the directions. Lynparza is usually taken twice a day at regular intervals about12 hours apart. When taking this medication, swallow the entire tablet without crushing, chewing, or breaking it. Lynparza affects the immune system, and patients may be more susceptible to infections, even serious or fatal infections, and doctors need to check patients regularly. Patients may also need to have a chest xray to make sure this medication is not having harmful effects on the lungs. Store medicine at room temperature, away from moisture and heat. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.